Cargando…
Mainstreamed genetic testing of breast cancer patients in two hospitals in South Eastern Norway
Studies have shown that a significant number of eligible breast cancer patients are not offered genetic testing or referral to genetic counseling. To increase access to genetic testing in South Eastern Norway, testing has since 2014 been offered directly to breast cancer patients by surgeons and onc...
Autores principales: | Grindedal, Eli Marie, Jørgensen, Kjersti, Olsson, Pernilla, Gravdehaug, Berit, Lurås, Hilde, Schlichting, Ellen, Vamre, Tone, Wangensteen, Teresia, Heramb, Cecilie, Mæhle, Lovise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101297/ https://www.ncbi.nlm.nih.gov/pubmed/32002722 http://dx.doi.org/10.1007/s10689-020-00160-x |
Ejemplares similares
-
“It was an important part of my treatment”: a qualitative study of Norwegian breast Cancer patients’ experiences with mainstreamed genetic testing
por: Strømsvik, Nina, et al.
Publicado: (2022) -
BRCA1 and BRCA2 mutation spectrum – an update on mutation distribution in a large cancer genetics clinic in Norway
por: Heramb, Cecilie, et al.
Publicado: (2018) -
BRCA mutation carrier detection. A model-based cost-effectiveness analysis comparing the traditional family history approach and the testing of all patients with breast cancer
por: Norum, Jan, et al.
Publicado: (2018) -
Current guidelines for BRCA testing of breast cancer patients are insufficient to detect all mutation carriers
por: Grindedal, Eli Marie, et al.
Publicado: (2017) -
The Norwegian PMS2 founder mutation c.989-1G > T shows high penetrance of microsatellite instable cancers with normal immunohistochemistry
por: Grindedal, Eli Marie, et al.
Publicado: (2014)